Dr. Christopher Pelloski (43221) has been recruited to The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute as the first director of pediatric radiation oncology. He also serves as director of the radiation oncology residency program and medical student education.
Pelloski, who brings considerable expertise in treating pediatric and adult central nervous system malignancies, holds the joint appointment with Nationwide Children’s Hospital for pediatric radiation oncology. His research interests include studying radiation resistance in pediatric cancers along with molecular biomarkers and translational research.
Pelloski received his medical degree from Northwestern University Medical School and completed his residency at M.D. Anderson Cancer Center in Houston. He is certified by the American Board of Radiology.
“Dr. Pelloski is an expert in his field and we are pleased to have him lead our pediatric radiation oncology program,” said Dr. Arnab Chakravarti, professor and chair of radiation oncology. “His joint appointment with Ohio State and Nationwide Children’s will strengthen our collaborative treatment of children with cancer. To have someone solely dedicated to the treatment and study of pediatric cancers will help us better serve the children of central Ohio.”
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (cancer.osu.edu) is one of only 40 Comprehensive Cancer Centers in the United States designated by the National Cancer Institute. Ranked by U.S. News & World Report among the top 20 cancer hospitals in the nation, The James is the 180-bed adult patient-care component of the cancer program at The Ohio State University. The OSUCCC-James is one of only seven funded programs in the country approved by the NCI to conduct both Phase I and Phase II clinical trials.